webinar register page

Webinar banner
Has the Pandemic been a tailwind for Biotech investing?
Interview with Bloomberg Senior Biotech Analyst, Dr Sam Fazeli

Dear Friends of o2h group,

We are delighted to announce that we are back with o2h ChaiTime Season 3 starting with our season’s first ChaiTime webinar on 5th March 2021, Friday @ 3.00pm GMT (10.30am EST/ 8.30pm IST).

We have all seen death rates decrease and vaccinations increase, does this mean that we are at the tailend of the pandemic? Well we all hope so; one of the trends that we have seen is certain industries to come through this stronger. The SPDR S&P Biotech ETF is making fresh highs; investors have been forced fed courses in epidemiology and biology and realise the importance of science on both the economy and society.

I am very excited to have the opportunity to have an exclusive 1-1 interview with Dr Sam Fazeli, a senior analyst @Bloomberg. He is one the world's leading and most respected biotech analysts in London with a career in the sector that spans over 20 years. He recently published an article on Bloomberg “Britain Deserves Some Credit for Leading the Covid-19 Fight’ which I will be quizzing him on during the webinar”. Given the ‘flack’ the government has received over its handling of the pandemic I was interested in his perspective as well as whether he believes the focus on biotech investing will be long-lasting and his view on public markets.

Mar 5, 2021 03:00 PM in London

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Sunil Shah.